Adaptive Biotechnologies Corp. logo

Adaptive Biotechnologies Corp.

Every immune system has a story to tell; the key is knowing how to listen.

654 employees · est. 2009 · Seattle, United States

VS
Immunai logo

Immunai

Mapping the Immune System with AI to Improve Health

174 employees · est. 2019 · New York, United States

Adaptive Biotechnologies Corp. is the older company (2009 vs 2019); Adaptive Biotechnologies Corp. is the larger of the two.

Side-by-Side Comparison

Adaptive Biotechnologies Corp. Immunai
Founded
2009 older 2019
Headquarters
Seattle, United States New York, United States
Employees
654 larger 174
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Pharmaceutical
Funding Stage
IPO Series B
Total Funding
$526.85M $300.50M
Funding Rounds
12 5
Services
clonoSEQ MRD Test, Clinical Portfolio & Pipeline, Biopharma Services, Immune Medicine Platform, Data-driven Product Development Target Discovery, Preclinical Evaluation, Clinical Trial Optimization, Data Generation, Data Augmentation, Compute and Validate Therapeutic Insights, Recommendation Engine
Target Customers
Clinicians, Biopharmaceutical Companies, Hematology Researchers, Oncologists, Healthcare Providers biopharmaceutical companies, research institutions, pharma companies
Taxonomy
Immune-driven Medicine, Immune Profiling, Adaptive Immune System, Immune Diagnostics, Minimal Residual Disease, Blood Cancer Detection, FDA Authorized Diagnostics, Therapeutics Development, Cancer Diagnostics, Autoimmune Disease Treatment, Infectious Disease Insights, Proprietary Technology, Clinical Research Collaboration, Precision Medicine Immune System Mapping, Single-cell Genomics, Biotech, Therapeutic Discoveries, Drug Development, Patient Outcomes, Biomarker Discovery, High-resolution Profiling, Immune Profiling, Cellular Response Analysis, Cancer Research, Genomic Technologies, High-dimensional Statistics, Single-cell Biology
Website
adaptivebiotech.com immunai.com
Adaptive Biotechnologies Corp. logo

About Adaptive Biotechnologies Corp.

Adaptive Biotechnologies Corp., founded in 2009 and headquartered in the United States, is at the forefront of immune-driven medicine. With the slogan, "Every immune system has a story to tell; the key is knowing how to listen," they exemplify innovation in the Biotechnology, Health Care, and Health...

Immunai logo

About Immunai

Immunai, founded in 2019, is a United States-based startup that is revolutionizing the Biotechnology and Pharmaceutical industries with its innovative approach. The company's slogan, "Mapping the Immune System with AI to Improve Health," reflects its mission to map and decode the immune system using...

We will tell you when either one moves

BounceWatch watches Adaptive Biotechnologies Corp. and Immunai for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Adaptive Biotechnologi... and Immunai — by email.

Frequently Asked Questions

Adaptive Biotechnologies Corp. — Every immune system has a story to tell; the key is knowing how to listen.. Immunai — Mapping the Immune System with AI to Improve Health. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Adaptive Biotechnologies Corp. has raised $526.85M while Immunai has raised $300.50M.
Adaptive Biotechnologies Corp. and Immunai operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Adaptive Biotechnologies Corp. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Adaptive Biotechnologies Corp. on 9 Jun 2026, and Immunai on 3 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy